Bright Minds Biosciences Stock Performance
| DRUG Stock | USD 38.59 3.26 9.23% |
Bright Minds holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -31.85, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bright Minds are expected to decrease by larger amounts. On the other hand, during market turmoil, Bright Minds is expected to outperform it. Use Bright Minds potential upside, and the relationship between the total risk alpha and kurtosis , to analyze future returns on Bright Minds.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 3.06 | Five Day Return (0.25) | Year To Date Return 1.9 K | Ten Year Return 34.85 | All Time Return 34.85 |
Last Split Factor 1:5 | Last Split Date 2023-07-14 |
1 | Revolution Medicines to Deliver Multiple Presentations at the 2024 AACR-NCI-EORTC Symposium and Host Investor Webcast | 10/07/2024 |
2 | Insider Trading | 10/15/2024 |
3 | Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models | 10/16/2024 |
4 | Bright minds biosciences sees 3.2 million stock purchase by Cormorant | 10/17/2024 |
5 | Global Cancer Antibody Drug Conjugates Market Size Forecast 2030 | 10/22/2024 |
6 | Myanmars lost generation battles trauma, drug addiction at jungle rehabilitation centre | 10/29/2024 |
7 | Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3 | 11/04/2024 |
8 | Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month | 11/13/2024 |
9 | Legislation introduced to reduce prescription drug shortages | 11/22/2024 |
| Begin Period Cash Flow | 11.6 M |
Bright |
Bright Minds Relative Risk vs. Return Landscape
If you would invest 110.00 in Bright Minds Biosciences on August 28, 2024 and sell it today you would earn a total of 3,749 from holding Bright Minds Biosciences or generate 3408.18% return on investment over 90 days. Bright Minds Biosciences is currently generating 18.7851% in daily expected returns and assumes 127.7146% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Bright, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bright Minds Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bright Minds' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bright Minds Biosciences, and traders can use it to determine the average amount a Bright Minds' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1471
| Best Portfolio | Best Equity | DRUG | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 127.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Bright Minds is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bright Minds by adding it to a well-diversified portfolio.
Bright Minds Fundamentals Growth
Bright Stock prices reflect investors' perceptions of the future prospects and financial health of Bright Minds, and Bright Minds fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bright Stock performance.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 242.02 M | ||||
| Shares Outstanding | 6.08 M | ||||
| Price To Book | 56.48 X | ||||
| EBITDA | (7.28 M) | ||||
| Net Income | (7.37 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 73.55 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (7.02 M) | ||||
| Earnings Per Share | (0.63) X | ||||
| Market Capitalization | 246.44 M | ||||
| Total Asset | 6.88 M | ||||
| Retained Earnings | (31.55 M) | ||||
| Working Capital | 6.53 M | ||||
About Bright Minds Performance
By analyzing Bright Minds' fundamental ratios, stakeholders can gain valuable insights into Bright Minds' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bright Minds has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bright Minds has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.23) | (1.29) | |
| Return On Capital Employed | (1.28) | (1.35) | |
| Return On Assets | (1.23) | (1.29) | |
| Return On Equity | (1.28) | (1.35) |
Things to note about Bright Minds Biosciences performance evaluation
Checking the ongoing alerts about Bright Minds for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bright Minds Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bright Minds is way too risky over 90 days horizon | |
| Bright Minds appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (7.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (7.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from aol.com: Legislation introduced to reduce prescription drug shortages |
- Analyzing Bright Minds' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bright Minds' stock is overvalued or undervalued compared to its peers.
- Examining Bright Minds' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bright Minds' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bright Minds' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bright Minds' stock. These opinions can provide insight into Bright Minds' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |